Eurofins Scientific Se · EURONEXT:ERF

Eurofins Scientific — Q1 2026 Earnings Presentation

13 slides from Eurofins Scientific's earnings presentation, Apr 22, 2026

  1. Slide 1: Q1 2026 Trading Update

    CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific (Ireland) Ltd, 2026. All rights reserved. This document contains information that is confidential and proprietary to Eurofins Scientific SE and / or its affiliates and is solely for the use of the personnel of Eurofins Scientific SE and all its af

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute or form part of, and should not be construed as, an offer or invitation to subscribe for or purchase securities in Eurofins Scientific S.E. and neither this document nor anything contained or referred to in it shall form the basis of, or be relied on

  3. Slide 3: Key financial and operational highlights

    Key financial and operational highlights Reported Revenues Key Highlights • Reported revenues in Q1 2026 grew 1.3% vs Q1 2025 including -4.8% headwind from FX Q1 2026 • Organic revenue growth was 2.6% vs Q1 2025, including a +0.1% adjustment for public working days (PWD) €1,789m • In Europe, organic

  4. Slide 4: Revenue bridge

    Revenue bridge (€m) 69 Q1 2026: +2.6%1 1,828 -8 • Organic revenue growth of 2.6% 5 1,789 44 • FX headwind of -4.8% in Q1, as the 1,767 Euro strengthened against most currencies compared to the prior year -88 • M&A contribution of €5m to consolidated revenues, with FY 2025 pro-forma annual revenues o

  5. Slide 5: Organic growth by activity, Q1 2026

    Organic growth by activity, Q1 2026 Revenues (€m) Commentary Organic growth +2.6%1 1,789 • North America and Northern Europe growth affected by unusually severe adverse weather 1,767 Life conditions, only partially recovered by the end of the quarter despite significant catch-up in March • Food & Fe

  6. Slide 6: Growth investments continued, with acquisitions closed in Q1 2026

    Growth investments continued, with 10 acquisitions closed in Q1 2026 Acquired companies generated revenues of €55m in 2025 North America Europe Rest of the World 3 acquisitions 6 acquisitions 1 acquisition Acquired: Acquired: Acquired: • Environment Testing businesses in • Environment Testing busine

  7. Slide 7: Agreement to divest Electrical & Electronic Testing demonstrates strategic focus

    Agreement to divest Electrical & Electronic Testing demonstrates strategic focus, and value embedded in Eurofins portfolio Divestment of business within Consumer & Technology Products Testing • On 14 April 2026, Eurofins announced an agreement to divest Electrical and Electronic Testing business (“M

  8. Slide 8: Reiterating objectives for FY 2026, mid-term and FY 2027

    Reiterating objectives for FY 2026, mid-term and FY 2027 • Eurofins targets mid-single-digit organic growth and potential revenues from acquisitions of €250m, consolidated at mid-year (€125m consolidated impact in 2026). • The adjusted EBITDA margin on total revenues is expected to show further prog

  9. Slide 9: Q&A

    Q&A CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific (Ireland) Ltd [2026]. All rights reserved. Any use of this material without the specific permission of an authorized representative of Eurofins Scientific (Ireland) Ltd is strictly prohibited. 9

  10. Slide 10: Appendix

    Appendix CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific (Ireland) Ltd [2026]. All rights reserved. Any use of this material without the specific permission of an authorized representative of Eurofins Scientific (Ireland) Ltd is strictly prohibited. 10

  11. Slide 11: Breakdown of revenue by Operating Segment

    Breakdown of revenue by Operating Segment 2024 2025 2026 As % of total €m Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Sales 850 897 873 929 3,549 893 962 950 1,024 3,829 957 53% Europe Organic growth in the Core 5.1% 3.5% 4.9% 2.9% 1.6% 3.6% 5.0% 3.3% 1.6% Business1 Sales 628 683 663 686 2,660 685 687 660 653

  12. Slide 12: Breakdown of revenue by Area of Activity

    Breakdown of revenue by Area of Activity 2024 2025 2026 As % of €m Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 total Sales 664 715 714 776 2,869 718 755 761 809 3,043 734 41% Life Organic growth in the Core 7.2% 6.7% 7.4% 5.1% 6.1% 7.2% 5.9% 6.1% 4.2% Business1 Sales 489 511 501 509 2,010 516 526 502 519 2,062

  13. Slide 13: Definitions / Alternative Performance Measures (APMs)

    Definitions / Alternative Performance Measures (APMs) Adjusted results – reflect the ongoing performance of the mature and recurring activities excluding “separately disclosed items”. Separately disclosed items – include one-off costs from network expansion, integration and reorganisation, discontin

Eurofins Scientific — Q1 2026 Earnings Presentation on 6ix